Venus Remedies gets marketing approval for gemcitabine and docetaxel from Serbia
Express Pharma
SEPTEMBER 19, 2023
Venus Remedies has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs. billion by 2029 at a compounded annual growth rate (CAGR) of 8.2 With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles. per cent from 2021 to 2030.
Let's personalize your content